共 5 条
- [1] Hormone therapy enhances anti-PD1 efficacy in premenopausal estrogen receptor-positive and advanced breast cancerCELL REPORTS MEDICINE, 2025, 6 (01)Chen, I-ChunLin, Ching-HungChang, Dwan-YingChen, Tom Wei-WuWang, Ming-YangMa, Wei-LiLin, Yi-TingHuang, Shu-MinHsu, Chia-LangLu, Yen-Shen
- [2] Depressed anti-HER2 CD4 Th1 responses correlate with residual disease following neoadjuvant therapy in HER2+breast cancer patients and can be restored by dendritic cell vaccinationCANCER RESEARCH, 2015, 75Datta, JashodeepBerk, ErikXu, ShuwenFitzpatrick, ElizabethLowenfeld, LeaGoodman, NoahLewis, DavidRoses, Robert E.DeMichele, AngelaCzerniecki, Brian J.
- [3] Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem AxisINTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (02): : 537 - 553Xuzhang, WendiLu, TingtingJin, WeiqiuYu, YongfengLi, ZimingShen, LanNiu, XiaominAi, XinghaoXia, LiliangLu, Shun
- [4] Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the ResponseFRONTIERS IN IMMUNOLOGY, 2019, 10Kodumudi, Krithika N.Ramamoorthi, GanesanSnyder, ColinBasu, AmritaJia, YongshengAwshah, SabrinaBeyer, Amber P.Wiener, DorisLam, LianZhang, HongtaoGreene, Mark, ICosta, Ricardo L. B.Czerniecki, Brian J.
- [5] The addition of radiation therapy to simultaneous targeting of PD-1 and IL2Rβγ enhances antigen-specific CD8 T cell anti-tumor immunity in pancreatic cancer modelCANCER RESEARCH, 2023, 83 (07)Hoen, MaureenPiper, MilesDarragh, Laurel B.Nugyen, DiemmyGadwa, JacobAmann, MariaDurini, GretaKnitz, MichaelVan Court, BenjaminPham, TiffanyKedl, RossUmana, PabloCodarri-Deak, LauraKlein, ChristianD'Alessandro, AngeloKaram, Sana D.